Skip to main content
Markdown filings API. Get API access →
OICS v0.3.3 class · Healthcare

Clinical-Stage Biotech

ID CLB HC.PH.BIO.CLB

Develops drugs, biologics or cell and gene therapies with no approved product on the market (no revenue, or milestones only); such a developer is here, not in contract research.

01

Where it sits

Sector, group and industry above this class, as placed in the current release. The sector and the industry link to their companies.

Sector
HC Healthcare in the standard Medicines, medical technology and the delivery of care.
Group
HC.PH Medicines & Life Sciences Developing and making medicines, and the tools and services for it.
Industry
HC.PH.BIO Biotechnology in the standard Biology-based drug developers.
02

Companies in this class

Companies whose primary class this is. The sector and industry pages and the screener count them the same way.

All companies1,679 Listed with filings979
Largest first Name Country

Counted by primary class: companies that are listed and have filings on FinancialFilings.

Company Ticker Country Market cap Filings
SpyGlass Pharma, Inc. SGP United States of America — 76
Psych Capital Plc PSY United Kingdom — 74
Suzhou Ribo Life Science Co., Ltd. 6938 Hong Kong — 73
Guangzhou Innogen Pharmaceutical Group Co., Ltd. 2591 Hong Kong — 72
Aktis Oncology, Inc. AKTS United States of America — 71
Definium Therapeutics, Inc. DFTX Canada — 71
Epi Biotech Co., Ltd. 446440 South Korea — 71
Deutsche Biotech Innovativ AG DBI Germany — 70
Lophos Holdings Inc. MESC Canada — 67
Odyssey Therapeutics, Inc. ODTX United States of America — 67
AnnJi Pharmaceutical Co., Ltd. 7754 Taiwan — 65
J-Pharma Co.,Ltd. 520A Japan — 65
Kailera Therapeutics, Inc. KLRA United States of America — 65
B&K CORPORATION LIMITED 2396 Hong Kong — 61
Avalyn Pharma Inc. AVLN United States of America — 58
Generate Biomedicines, Inc. GENB United States of America — 58
Conexeu Sciences Inc. CNXU United States of America — 56
Eikon Therapeutics, Inc. EIKN United States of America — 56
Kardigan, Inc. Common Stock KARD United States of America — 55
Seaport Therapeutics, Inc. SPTX United States of America — 55
Sunhawk Vision Biotech, Inc. 7759 Taiwan — 53
Parabilis Medicines, Inc. PBLS United States of America — 52
Hemab Therapeutics Holdings, Inc. COAG United States of America — 51
Kanaph Therapeutics Inc. 0082N0 South Korea — 50
AgomAb Therapeutics NV American Depositary Shares AGMB United States of America — 48
Anbogen Therapeutics, Inc. 7784 Taiwan — 48
U-Neuron Biomedical Inc. 6973 Taiwan — 48
Attovia Therapeutics, Inc. — United States of America — 47
Curasight A/S CURAS Denmark — 45
Pharmasaga Company Limited 7878 Taiwan — 44
Aimed Bio Inc. 0009K0 South Korea — 43
Braveheart Bio, Inc. — United States of America — 43
Rznomics Inc. 476830 South Korea — 43
LongBio Pharma (Suzhou) Co., Ltd. — Hong Kong — 42
ANYA BIOPHARM INC. 7776 Taiwan — 41
EVOPOINT BIOSCIENCES CO., LTD. 688837 China — 41
Veraxa Biotech AG Ordinary Shares VRXA Switzerland — 41
QuadMedicine Inc. 464490 South Korea — 38
Vaxart Inc VXRT United States of America — 38
Dasher Neuroscience Holdings Inc. 7829 Taiwan — 37
OBIGEN PHARMA, INC. 7876 Taiwan — 37
Scribe Therapeutics, Inc. — United States of America — 37
TenNor Therapeutics (Suzhou) Limited — Hong Kong — 37
BlossomHill Therapeutics, Inc. — United States of America — 36
FullHope Biomedical Co., Ltd. 7773 Taiwan — 36
Polaryx Therapeutics, Inc. PLYX United States of America — 35
METiS TechBio Co., Ltd — China — 33
Obsidian Therapeutics, Inc. — United States of America — 32
Apnimed, Inc. — United States of America — 31
Herantis Pharma Oyj HRTIS Finland — 31

Companies in Biotechnology → Open in the screener →

03

Boundaries

Other names for this activity, and where neighboring activities go instead.

Also known as

preclinicaldrug developer

Not here
Sent here from
04

Other classes in Biotechnology

Commercial Biotech CMB HC.PH.BIO.CMB

Research-led company whose approved medicines, which it discovered, are in one or two therapeutic areas; it moves to Branded Prescription Drugs only after two consecutive annual reports with approved products in three or more.

05

Permanent link

https://financialfilings.com/oics/CLB/

This page is keyed by the class ID CLB. IDs are assigned in v0.3 and freeze at v1.0; from then on an ID is never renamed or reused, and if the class moves in the tree, its ID and this URL stay the same.

See it in the full standard Download the standard